Navigation Links
Regenesis Biomedical Appoints Scientific Advisory Board Composed of Life Science and Electronics Experts
Date:5/20/2008

Thought leaders from around the world converge on Regenesis

SCOTTSDALE, Ariz., May 20 /PRNewswire/ -- Regenesis Biomedical, Inc., a medical technology company that markets the Provant(R) Wound Therapy System, announced today the formation of a Scientific Advisory Board. The Board's purpose is to guide advanced scientific investigations into the mechanism of action of Provant, new product development, and further application of Regenesis' platform technology to clinical and industrial applications.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080422/LATU008)

"This is another milestone in Regenesis' strategic plan to advance the science of wound care," said Virginia Rybski, Acting President of Regenesis. "Our Scientific Advisory Board is composed of academics and thought leaders who are experts in the field of bioelectrochemistry, which is the interaction between energy and living systems. This group will assist in our evidenced- based decision-making as we further expand our platform technology into next generation products."

The Regenesis Scientific Advisory Board brings together experts recognized in their fields:

* Metin Akay, Ph.D., Professor and Chairman of the Harrington Department

of Bioengineering at Arizona State University, and founding chairman of

the International IEEE Conference on Neural Engineering.

* Hunt Dabney, President, Hunt Dabney & Associates. Leading expert in

precision medical electronics and regulatory compliance mitigation.

Holds 7 US patents with 7 patents pending.

* Colin McCaig, Ph.D., Professor of Physiology and Head of School of

Medical Sciences at the University of Aberdeen, Scotland. Researches

role of endogenous direct current electrical fields in development and

regeneration of tissues in cell culture, excised tissues and whole

animals.

* Dennis Orgill, M.D., Ph.D., Associate Professor at Harvard Medical

School, Associate Chief of Plastic Surgery and Principal Investigator

of the Wound Healing and Tissue Engineering Laboratory at Brigham and

Women's Hospital.

About the Provant Wound Therapy System

Provant delivers cell proliferation induction(R) (CPI(R)) therapy based on Regenesis' proprietary pulsed radio frequency energy (PRFE) core technology platform. PRFE uses an optimized radiofrequency signal to stimulate dormant cells, causing them to replicate and to produce natural growth factors and other gene expression products, which facilitate reduction of the pain and edema associated with post-operative wound healing in soft tissues. We believe Provant is effective, economical, and easy-to-use.

About Regenesis Biomedical

Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant Wound Therapy System. Our customers include health care facilities and providers that serve patients with wounds being treated by acute care hospitals, long- term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.

Contact:

Regenesis Biomedical, Inc.

Media: Scott Robey, VP Marketing robey@regenesisbiomedical.com

Clinicians: Rick Isenberg, MD, VP Clinical Affairs

isenberg@regenesisbiomedical.com

Investors: Virginia Rybski, Acting President

rybski@regenesisbiomedical.com

http://www.regenesisbiomedical.com

480-970-4970


'/>"/>
SOURCE Regenesis Biomedical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing
2. Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R)
3. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
4. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
5. Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
6. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
7. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
8. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
9. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
10. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
11. Environmental Tectonics Corporations BioMedical Division Announces New Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... NEW YORK , Jan. 23, 2017  Spherix ... development company committed to the fostering of technology and ... its active patent infringement lawsuits. Anthony ... we enter 2017, we will continue to communicate with ... Equitable IP and our due diligence on other patent ...
(Date:1/23/2017)... , Jan. 23, 2017 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" ... from the New Zealand based ... The data showed remarkable results in reducing inflamed protein ... control patients. It is believed that this is the ... of this type can be made between epigenetic regulation ...
(Date:1/23/2017)... ... January 23, 2017 , ... Calvert Labs, Inc. announced today ... Senior Director, Safety Pharmacology. Dr. Thomas earned his M.Sc. and Ph.D. in ... as an academic and industry preclinical drug developer spans more than three decades. ...
(Date:1/23/2017)... ... January 23, 2017 , ... AxioMed will be ... (CANS) annual meeting in Montego Bay, Jamaica from January 26-28th. “We’re excited to ... for surgeons to experience the simplicity of the surgical technique,” said Jake Lubinski, ...
Breaking Biology Technology:
(Date:12/15/2016)... BADEN-BADEN, Germany , December 15, 2016 /PRNewswire/ ... services provider, today announced an agreement with NuData Security, ... join forces. The partnership will enable clients to focus on ... with local data protection regulation. ... In order to provide a one-stop ...
(Date:12/15/2016)... Dec. 15, 2016  There is much more to ... starting the engine. Continental will demonstrate the intelligence of ... Vegas . Through the combination of the keyless ... and biometric elements, the international technology company is opening ... and authentication. "The integration of biometric elements ...
(Date:12/8/2016)... 8, 2016  Singulex, Inc., the leader in Next ... into a license and supply agreement with Thermo Fisher ... provides Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), ... is used to diagnose systemic bacterial infection and sepsis ... to aid in assessing the risk of critically ill ...
Breaking Biology News(10 mins):